Cytotheryx is a platform technology company focused on the development of a consistent, high-quality source of primary human hepatocytes, or liver cells, to address the critical shortage of these cells currently available. The proprietary technology was originally developed at, and licensed from, the Mayo Clinic in Rochester, MN.